Update date
31 Dec 2022
Shareable Research Card
This metric view shows ViewRay, Inc. return on equity history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported return on equity: -94%. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Dec 2022
Page type
Metric history
Latest period
2022
SEC-backed company facts were refreshed from filings filed on 11 May 2023.
Benchmark Context
ViewRay, Inc. is outside the visible top 120 companies for return on equity in the current sample.
Compared with
Compared with 120 companies reporting return on equity in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about -0.1x the current sample midpoint. Return On Equity is down about 26% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Latest period: 2022. Period end: 31 Dec 2022. Units: %. Frequency: annual and quarterly.
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Return On Equity levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Wellgistics Health, Inc. (wgrx) | 141760% | Quarter - 31 Dec 2025 | Open Wellgistics Health, Inc. Return On Equity |
| 2 | XCF Global, Inc. (safx) | 77635% | Quarter - 31 Dec 2025 | Open XCF Global, Inc. Return On Equity |
| 3 | Cardiff Lexington Corp (cdix) | 49573% | Year - 31 Dec 2025 | Open Cardiff Lexington Corp Return On Equity |
| 4 | Bionik Laboratories Corp. (bnkl) | 46191% | Quarter - 31 Mar 2023 | Open Bionik Laboratories Corp. Return On Equity |
| 5 | Savara Inc (svra) | 43610% | Year - 31 Dec 2025 | Open Savara Inc Return On Equity |
| 6 | Athenex, Inc. | 25553% | Quarter - 31 Dec 2022 | Open Athenex, Inc. Return On Equity |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2022 | -94% | -19% | -26% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -74% | -8% | -12% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -66% | +15% | +19% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -82% | -12% | -18% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -69% | -490% | -116% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | 421% | +263% | +166% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | 158% | 01 Jan 2016 | 31 Dec 2016 |
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q1 2015 | -4104016% | 01 Jan 2015 | 31 Mar 2015 |